Law.com International November 30, 2022 By Anne Bagamery, Coorespondent, Paris Jeantet has recruited a 14-person team, including three partners, from a rival French firm to create a new multidisciplinary department dedicated to energy transition and sustainable development. The move is part of a growth strategy for Jeantet, an elite firm with headquarters in Paris and offices around the world. It is also in line with what many firms in Europe have done to attract business as more countries, and companies, grapple with environmental concerns and energy transition...
Jeantet is a leading French independent business law firm, delivering tailored, high value-added services, with a commitment to ethics and human values.
Mindful of the economic, technological, sectoral and legal changes impacting our clients, our people have the skills and expertise to anticipate and work with you to create workable, reliable solutions to suit your particular challenges.
With our solid market expertise, Jeantet offers exceptional legal, advisory and litigation expertise, combined with an entrepreneurial culture, to ensure a successful outcome for our clients.
Jeantet offices in Paris, Casablanca, Luxembourg, Geneva, Budapest and Kiev have more than 140 lawyers, including 30 partners.
Year this Office was Established: 1924
Lawyers Worldwide: 120
Areas of Practice
The new EU-US Trans-Atlantic Data Privacy Framework
On 25 March 2022, the European Commission and the United States Government announced an “agreement in principle” on a new EU-US Trans-Atlantic Data Privacy Framework (the Framework). The purpose of this is to address the concerns that the Court of Justice of the European Union (CJEU) raised in the Schrems II decision, and thus allow the flow of personal data from the EU to the US in a manner that is compliant with the requirements of the GDPR. Previous position Transatlantic data transfers had been permitted under the Privacy Shield following an adequacy decision by the EU Commission...
JEANTET ADVISES THE CHINA MEDICAL SYSTEM GROUP ON ITS ACQUISITION OF A STAKE IN THE COMPANY EYE TECH CARE
Paris, September 15, 2022 – Jeantet has advised the Chinese group China Medical System in the context of (i) a stake and acquisition of a stake, through certain group subsidiaries, of approximately 33.4% of the share capital of the French company Eye Tech Care and (ii) the signing of a licensing, collaboration and distribution agreement for the EyeOP1® ultrasound glaucoma treatment device. Based in Shenzhen, the China Medical System group is a leader in the development and distribution of new medical treatments, particularly in the areas of dermatology and ophthalmology...
JEANTET ADVISED LBO FRANCE ON THE ACQUISITION OF A MAJORITY STAKE IN BAOBAG
Jeantet advised the investment fund LBO France on the acquisition of a majority stake in the French company Baobag, alongside AfricInvest, BNP Paribas Développement and the management team, led by Fabrice Saffré. Founded in 1985, LBO France, the leading private equity firm in France with €6.3 billion of capital raised, holds stakes in 37 companies and contributes to their development in many sectors of activity (fashion, science, health, real estate, digital, etc.)...